C-reactive protein, TNF-α, vascular endothelial growth factor, and IL-6 represent molecules involved in both atherogenesis and IBD, and their increased serum levels among the IBD patients confirm the fact that atherogenesis is accelerated among this class of patients [57, 69]. The gene discussed is VEGFA; the disease is inflammatory bowel disease.